Skip to main content

Kathleen Ann Cooney

George Barth Geller Distinguished Professor of Medicine
Medicine, Medical Oncology
DUMC 3703, Duke North Hospital Suite 1102, Durham, NC 27710
40 Duke Medicine Circle, Davison Bldg, Suite 401, 401A, Durham, NC 27710

Overview


Dr. Cooney is Chair of the Duke Department of Medicine. 

She is a medical oncologist focused in caring for men with prostate cancer, and is internationally known for her investigations focused on the genetic epidemiology of prostate cancer.

Her research led to the important discovery of a recurrent mutation in the HOXB13 gene that increases the chances of being diagnosed with prostate cancer and is estimated to account for 5 percent of hereditary prostate cancer cases worldwide. Since men with HOXB13 mutations are at an increased risk of prostate cancer, they may benefit from participation in screening and potentially prevention protocols in the future.

Dr. Cooney’s research continues with a focus on identifying germline mutations associated with lethal and aggressive prostate cancer as well as prostate cancer in African American men.

Current Duke Appointments & Affiliations


George Barth Geller Distinguished Professor of Medicine · 2020 - Present Medicine, Medical Oncology, Medicine
Professor of Medicine · 2018 - Present Medicine, Medical Oncology, Medicine
Chair, Department of Medicine · 2018 - Present Medicine, Clinical Science Departments
Member of the Duke Cancer Institute · 2018 - Present Duke Cancer Institute, Institutes and Centers
Member of Duke Molecular Physiology Institute · 2022 - Present Duke Molecular Physiology Institute, Institutes and Centers

Recent News Items


Published September 16, 2025
1 in 12 Patients with Multiple Cancers Carry Inherited Genetic Risk
Published December 1, 2022
Family History, Gene Variants Put Black Men at Risk for Early Prostate Cancer
Published April 14, 2020
Duke Awards 29 University Distinguished Professorships

View All News Items

Recent Scholarly Works


Prostate Cancer, Genetic Susceptibility, and Risk of Chronic Non-Urological Complications.

Journal article Prostate · June 2026 BACKGROUND: Chronic nonurological complications are common among prostate cancer (PCa) survivors; however, their spectrum, magnitude, and genetic contribution remain poorly characterized. METHODS: We evaluated 15 commonly reported nonurological complicatio ... Full text Link to item Cite

Association between the rs72725854(A>T) allele and prostate cancer in males of African ancestry in a US population-based database.

Conference Journal of Clinical Oncology · June 1, 2026 10504Background: Black males have a 70% excess incidence of and two-fold higher morta ... Full text Cite
View All Scholarly Works

Recent Grants


Genetic Variation in Cancer Risk and Outcomes in African Americans

ResearchPrincipal Investigator · Awarded by Wayne State University · 2024 - 2030

Characterizing the Genetic Landscape of Prostate Cancer in Young African American Men - HDRA

ResearchPrincipal Investigator · Awarded by Department of Defense · 2016 - 2022

The Contribution of Rare Variants in Familial Clustering of Prostate and Breast Cancer in African Americans

ResearchPrincipal Investigator · Awarded by Wayne State University · 2018 - 2020

View All Grants

Education


University of Pennsylvania, School of Medicine · 1984 M.D.